We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

75 hedge funds and large institutions have $289M invested in Forte Biosciences in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 18

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

21% more funds holding

Funds holding: 62 → 75 (+13)

6% more capital invested

Capital invested by funds: $273M → $289M (+$16.1M)

0.19% more ownership

Funds ownership: 2.36% → 2.55% (+0.19%)

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
23
Reduced
14
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$23.8M
2
BlackRock
BlackRock
New York
+$18.5M
3
State Street
State Street
Massachusetts
+$6.54M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.06M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.28M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$7.62M
2
O
OrbiMed
New York
-$5.47M
3
Millennium Management
Millennium Management
New York
-$5.11M
4
ACM
Altium Capital Management
New York
-$4.61M
5
BI
BVF Inc
California
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
76
OrbiMed
New York
– -$5.47M -6,387 Closed
ACM
77
Altium Capital Management
New York
– -$4.61M -5,382 Closed
Susquehanna International Group
78
Susquehanna International Group
Pennsylvania
– -$1.8M -2,102 Closed
ECM
79
ExodusPoint Capital Management
New York
– -$1.54M -1,801 Closed
GPCM
80
Granite Point Capital Management
Massachusetts
– -$1.51M -1,760 Closed
Renaissance Technologies
81
Renaissance Technologies
New York
– -$1.35M -1,577 Closed
HF
82
HRT Financial
New York
– -$1.09M -1,270 Closed
California Public Employees Retirement System
83
California Public Employees Retirement System
California
– -$617K -720 Closed
Squarepoint
84
Squarepoint
New York
– -$397K -463 Closed
SSA
85
Schonfeld Strategic Advisors
New York
– -$347K -406 Closed
SC
86
Sepio Capital
Utah
– -$326K -381 Closed
TCA
87
Transcend Capital Advisors
New Jersey
– -$274K -320 Closed
LP
88
LMR Partners
United Kingdom
– -$224K -262 Closed
BCM
89
Bridgeway Capital Management
Texas
– -$217K -253 Closed
VF
90
Virtu Financial
New York
– -$212K -247 Closed
Qube Research & Technologies (QRT)
91
Qube Research & Technologies (QRT)
United Kingdom
– -$210K -245 Closed
MWP
92
Meridian Wealth Partners
Pennsylvania
– -$3K -3 Closed
SFS
93
Sowell Financial Services
Arkansas
– -$1K -1 Closed
1 2 3
4

FBRX Hedge Fund Activity: Q2 2021 in Review

75 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2021, worth a combined $289M — up 5.9% from $273M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new FBRX positions and 18 closed out — a net gain of 13 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Fred Alger Management, adding an estimated $23.8M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $7.62M.

  • 75 institutional investors held Forte Biosciences (FBRX) as of Q2 2021, up from 62 in Q1 2021.
  • Funds reported $289M of Forte Biosciences stock for Q2 2021, up 5.9% quarter-over-quarter.
  • 31 funds opened new Forte Biosciences positions in Q2 2021 and 18 closed out, a net change of +13 holders.
  • The largest Forte Biosciences buyer in Q2 2021 was Fred Alger Management, an estimated $23.8M added.
  • The largest Forte Biosciences seller in Q2 2021 was ArrowMark Colorado Holdings, an estimated $7.62M sold.

Based on aggregated 13F filings for Q2 2021.